Skip to main content
Fig. 6 | Radiation Oncology

Fig. 6

From: Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy

Fig. 6

Decision curve analysis of PFS and OS were compared between the IBM score and clinical stage in the training and validation cohort, respectively. a DCA of OS for the training cohort; b DCA of PFS for the training cohort; c DCA of OS for the validation cohort; d DCA of PFS for the validation cohort. The y-axis represents the net benefit. The x-axis represents the threshold probability. Across the full range of threshold probabilities, the horizontal black line indicated that no patient chose to undergo follow-up, and the green line indicated that all patients underwent follow-up. The red line represented IBM score. The blue line represented clinical stage. Compared to the clinical stage, the IBM score had the higher net benefit. DCA, decision curve analysis; IBM, imaging biomarker; OS, overall survival; PFS, progression-free survival

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us